Roy Weiler

An experienced professional with deep expertise in strategic planning and business transformation, focusing on the integration of business and technology and commercialization of science for a variety of life sciences companies including Genentech/Roche, Merck, Bristol-Myers Squibb, Amgen, Bayer, Boston Scientific, and others. Over the course of a 25+ year career, have developed and implemented business strategies, product roadmaps, market research activities, forecast models and roll-out plans.
Have managed high-profile business transformation assignments and led change management, product development activities, and mergers and acquisitions. Specialized in decision making, program and project management, synthesizing complex ideas into a clear and actionable strategy, and addressing and resolving problems. Have extensive experience with supporting internal and external business stakeholders, motivating cross-functional teams, and managing multiple assignments in key life sciences industries including Pharmaceutical, Biotechnology, Medical Devices and Diagnostics.